Distribution of lymph node metastasis and prognosis in duodenal bulb tumors: A multicenter retrospective study.
Abstract
797 Background: Duodenal tumors, especially duodenal bulb tumors, is a relatively rare malignancy of the gastrointestinal tract. The optimal surgical procedure for primary duodenal tumors has not been established because of its low incidence. The purpose of this study was to examine the distribution of lymph node (LN) metastasis in duodenal bulb tumors. Specifically, in T1a and T1b tumors, we aimed to evaluate the feasibility of distal gastrectomy with duodenal bulb resection combined with lymphadenectomy of regional gastric LNs. Methods: Data from patients who underwent surgery for either adenocarcinoma or neuroendocrine tumor located in the duodenal bulb between 2000 and 2020 were retrospectively analyzed from five high-volume centers in Japan. Patient background, clinicopathological factors, type of surgery, distribution of LN metastasis, and long-term outcomes were evaluated. Results: Of the 128 patients evaluated, LN metastasis was observed in 36%. The frequency of LN metastasis in T1b was 18%. Metastatic LNs were identified in #3, #5, #6, #8a, #8p, #12a, and #13 in T1b. The distribution of LN metastasis in T1b was similar between adenocarcinoma and neuroendocrine tumors. The 3 years overall survival rate in T1a, T1b, and T2–4 was 100%, 93%, and 64%, respectively. ln T1b, while there were three patients with a recurrence, two cases were observed in distant organs without regional LNs, and one patient who underwent pancreaticoduodenectomy had metastasis in the gastric regional LNs. Conclusions: Based on the distribution of LN metastasis with pT1, distal gastrectomy with duodenal bulb resection and regional LN dissection is considered a curative treatment. Conversely, pancreaticoduodenectomy is recommended in tumors with T2 or deeper.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (16)
Kazuhiko Hisaoka
Department of Surgery, Keio University School of Medicine, Tokyo, Japan
Satoru Matsuda
Department of Surgery, Keio University School of Medicine, Tokyo, Japan
Hirofumi Kawakubo
Department of Surgery, Keio University School of Medicine, Tokyo, Japan
Masashi Takeuchi
Department of Surgery, Keio University School of Medicine, Tokyo, Japan
Takeyuki Wada
Gastric Surgery Division, National Cancer Center Hospital, Tokyo, Japan
Shigeki Sekine
Department of Pathology, Keio University School of Medicine, Tokyo, Japan
Takeshi Takamoto
Department of Hepatobiliary Surgery, National Cancer Center Hospital, Tokyo, Japan
Mai Tsutsui
Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan
Masahiro Yura
Department of Gastric Surgery, National Cancer Center Hospital East, Kashiwa, Japan
Hiroki Ishida
Yoshihiro Ono
Division of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
Satoshi Kamiya
Department of Surgery, Keio University School of Medicine, Tokyo, Japan
Etsuro Bando
Souya Nunobe
Department of Gastroenterological Surgery, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
Takahiro Kinoshita
Department of Gastric Surgery, National Cancer Center Hospital East, Tokyo, Japan
Yuko Kitagawa